Intervention and comparator {#Sec2}
===========================

The intervention group will receive Solution Focused Brief Therapy 2--4 times within a 2 week period through telecommunication (e.g., using a platform such as Zoom). The comparators will be assigned to the waitlist group. They will also receive 2--4 sessions of counseling service after the 1 month follow-up data is collected.

Main outcomes {#Sec3}
=============

The primary outcome measures of the study are intended to assess the difference in adolescents' anxiety levels when comparing the SFBT group and the waitlist group. Level of anxiety will be measured by two measurements: GAD-7 and STAI-Y (C). Follow up 2 weeks and 1 month.

Baseline scores (GAD-7, STAI-Y(C), PHQ-9, CSS) will be collected from all participants and their legal guardian (Spence Children's Anxiety Scale-Parent report, Patient Health Questionnaire − 9) before beginning treatment. After 2 weeks' treatment, participants from both the intervention group and waitlist group will complete the assessments (GAD-7, STAI-Y(C), PHQ-9, CSS, CSQ-8), and their legal guardian will also complete several assessments (SCAS-Parent report, PHQ-9). After 1 month of treatment, data will be collected again.

Note: GAD-7 (Generalized Anxiety Disorder-7); STAI-Y(C) (State-Trait Anxiety Inventory); PHQ-9 (Patient Health Questionnaire-9); CSS (Coping Style Scale for Secondary School Students); CSQ-8 (Client Satisfaction Questionnaire-8), SCAS (Spence Children's Anxiety Scale).

Randomization {#Sec4}
=============

The Random Number Generator, an internet-based randomization tool, is used to assign participants to the intervention group and waitlist group. The allocation ratio is 1:1.

Blinding (masking) {#Sec5}
==================

Participants will be informed about the group assignment due to the nature of the study design. The research assistant who will have access to the outcome data is blinded to group assignment.

Numbers to be randomized (sample size) {#Sec6}
======================================

The study plans to enroll a total of 76 participants. Thirty-eight participants are to be randomized to each group.

Trial status {#Sec7}
============

The Protocol version number is 02, with ethical approval number 202003130012. The recruitment is ongoing. It started on March 20th, and we estimate it will finish by the 30 June 2020.

Trial registration {#Sec8}
==================

The trial was registered with the Chinese Clinical Trial Registry on March 20th, 2020. Registration number is ChiCTR2000030989.

Full protocol {#Sec9}
=============

The full protocol is attached as an additional file, accessible from the Trials website (Additional file [1](#MOESM1){ref-type="media"}). In the interest of expediting dissemination of this material, the familiar formatting has been eliminated; this letter serves as a summary of the key elements of the full protocol.

Supplementary information
=========================

 {#Sec10}

**Additional file 1:** Full-study protocol in Chinese.
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